Posaconazole, serum or plasma-994

Test info

  
Posaconazole, serum or plasma
  
994
  
LAB994
  
MSO
  
Noxafil
  

Prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients and treatments of oropharyngeal candidiasis

Specimen

  
Serum
  
  
1.0 mL
  
0.5 mL
  

Do not use a gel barrier tube.

The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending upon the specimen volume and storage times, the decrease in drug level due to absorption may be clinically significant.

  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
  
EDTA plasma
  
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting

  
  1. Spin
  2. Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as EDTA plasma, within two (2) hours of sample collection
  

Refrigerated (preferred) - 14 days

Ambient - 14 days

Frozen - 14 days

Performance

  
LabCorp Burlington (700265): R-NX
  
Mo - Fr
  
2 - 7 days
  

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)

Clinical and Interpretive info

  

An interpretive report will be provided

Billing

  
80187
  
Result 53731-6

Tracking

  
05/24/2019
  
03/03/2021